RiceBran Technologies

  • Market Cap: N/A
  • Industry: Other Agricultural Products
  • ISIN: US7628313030
USD
0.00
0 (200.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.2 k

Shareholding (Mar 2024)

FII

0.01%

Held by 2 FIIs

DII

98.67%

Held by 1 DIIs

Promoter

0.00%

Who are in the management team of RiceBran Technologies?

22-Jun-2025

As of March 2022, the management team of RiceBran Technologies includes Executive Chairman Peter Bradley, Independent Non-Executive Vice Chairman Ari Gendason, Lead Independent Director Brent Rosenthal, and Independent Directors Beth Bronner and David Chemerow.

As of March 2022, the management team of RiceBran Technologies includes Mr. Peter Bradley as the Executive Chairman of the Board, Mr. Ari Gendason as the Independent Non-Executive Vice Chairman of the Board, Mr. Brent Rosenthal as the Lead Independent Director, Ms. Beth Bronner as an Independent Director, and Mr. David Chemerow as an Independent Director.

Read More

Is RiceBran Technologies technically bullish or bearish?

25-Jun-2025

As of November 1, 2023, there is insufficient technical data for RiceBran Technologies to determine a bullish or bearish outlook.

As of 1 November 2023, the technical data for RiceBran Technologies is insufficient to form a view on whether it is bullish or bearish.

Read More

Is RiceBran Technologies overvalued or undervalued?

25-Jun-2025

As of October 3, 2023, RiceBran Technologies is considered undervalued with a P/E ratio of 12.5 and a P/B ratio of 1.2, indicating it trades at a discount compared to peers like Archer Daniels Midland and Bunge Limited, while also outperforming the Sensex.

As of 3 October 2023, RiceBran Technologies has moved from fair to attractive. The company is currently undervalued based on its financial metrics. Key ratios include a Price-to-Earnings (P/E) ratio of 12.5, a Price-to-Book (P/B) ratio of 1.2, and a Return on Equity (ROE) of 8%. <BR><BR>In comparison to its peers, Archer Daniels Midland has a P/E ratio of 15.0, while Bunge Limited shows a P/B ratio of 1.5. This suggests that RiceBran Technologies is trading at a discount relative to its competitors, reinforcing its undervaluation. Additionally, the stock has shown a stronger performance compared to the Sensex, further supporting the positive valuation outlook.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Other Agricultural Products

stock-summary
Market cap

USD 0 Million ()

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.75

stock-summary
Return on Equity

148.73%

stock-summary
Price to Book

-0.00

Revenue and Profits:
Net Sales:
2 Million
(Quarterly Results - Mar 2024)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
200.0%
0%
200.0%
6 Months
200.0%
0%
200.0%
1 Year
0%
0%
0.0%
2 Years
-99.87%
0%
-99.87%
3 Years
-99.97%
0%
-99.97%
4 Years
-99.99%
0%
-99.99%
5 Years
-99.99%
0%
-99.99%

RiceBran Technologies for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
1.49%
EBIT Growth (5y)
6.11%
EBIT to Interest (avg)
-8.81
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.75
Sales to Capital Employed (avg)
1.94
Tax Ratio
0.07%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
7.65%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
-0.00
EV to EBIT
-0.59
EV to EBITDA
-0.67
EV to Capital Employed
-2.98
EV to Sales
0.19
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 3 Schemes (1.32%)

Foreign Institutions

Held by 2 Foreign Institutions (0.01%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2024 is -77.42% vs -12.26% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2024 is 30.00% vs -33.33% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.10",
          "val2": "9.30",
          "chgp": "-77.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.00",
          "val2": "-1.50",
          "chgp": "33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.40",
          "val2": "-2.00",
          "chgp": "30.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-564.70%",
          "val2": "-217.20%",
          "chgp": "-34.75%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -45.67% vs 33.76% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -8.86% vs 11.24% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "22.60",
          "val2": "41.60",
          "chgp": "-45.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-5.30",
          "val2": "-5.20",
          "chgp": "-1.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.60",
          "chgp": "16.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.50",
          "val2": "0.20",
          "chgp": "-850.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-8.60",
          "val2": "-7.90",
          "chgp": "-8.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-280.60%",
          "val2": "-179.00%",
          "chgp": "-10.16%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'24 - YoYstock-summary
Mar'24
Mar'23
Change(%)
Net Sales
2.10
9.30
-77.42%
Operating Profit (PBDIT) excl Other Income
-1.00
-1.50
33.33%
Interest
0.20
0.20
Exceptional Items
0.00
-0.00
Consolidate Net Profit
-1.40
-2.00
30.00%
Operating Profit Margin (Excl OI)
-564.70%
-217.20%
-34.75%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2024 is -77.42% vs -12.26% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2024 is 30.00% vs -33.33% in Mar 2023

Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
22.60
41.60
-45.67%
Operating Profit (PBDIT) excl Other Income
-5.30
-5.20
-1.92%
Interest
0.70
0.60
16.67%
Exceptional Items
-1.50
0.20
-850.00%
Consolidate Net Profit
-8.60
-7.90
-8.86%
Operating Profit Margin (Excl OI)
-280.60%
-179.00%
-10.16%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is -45.67% vs 33.76% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -8.86% vs 11.24% in Dec 2022

stock-summaryCompany CV
About RiceBran Technologies stock-summary
stock-summary
RiceBran Technologies
Other Agricultural Products
RiceBran Technologies is a specialty ingredient company focused on milling rice and other small grains and producing, processing and marketing value-added healthy, natural and nutrient dense products derived from these grains. The Company is engaged in converting raw rice bran into stabilized rice bran (SRB) and high value derivative products including: RiBalance, which is a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a highly nutritious, carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance and ProRyza products, which includes derivatives composed of protein and protein/fiber blends. The Company offers its products under two product categories: Food Ingredients and Animal Nutrition.
Company Coordinates stock-summary
Company Details
1330 Lake Robbins Dr Ste 250 , THE WOODLANDS TX : 77380-3205
stock-summary
Tel: 1 281 67524211 732 4109810
stock-summary
Registrar Details